Asset Publisher

Unexpected effect of MS drug

Unexpected effect of MS drug

Karl Carlström and Fredrik Piehl

Photo: Stefan Zimmerman

 

Researchers at CMM have studied the mechanism of action of a drug used to treat multiple sclerosis. The results, which are published in the journal Nature Communications, show that the drug affects cells in the innate immune system and that there is an unexpected link between therapeutic effect and an increase in the production of reactive oxygen species.

To read more, please click here 

 

Publication

”Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes”.

Karl E. Carlström, Ewoud Ewing, Mathias Granqvist, Alexandra Gyllenberg, Shahin Aeinehband, Sara Lind Enoksson, Antonio Checa, Tejaswi VS. Badam, Jesse Huang, David Gomez-Cabrero, Mika Gustafsson, Faiez Al Nimer, Craig E. Wheelock, Ingrid Kockum, Tomas Olsson, Maja Jagodic and Fredrik Piehl. 

Nature Communications, 12 July 2019. doi:10.1038/s41467-019-11139-3

 

NEWS

Anca Catrina, Wallenberg Clinical Scholar 2020

Anca Catrina, Wallenberg Clinical Scholar 2020 We congratulate our CMM researcher Professor Anca Catrina, Group Leader at Karolinska Institutet and senior physician, who has been appointed...

Junior Investigator Award to Carmen Gerlach

Junior Investigator Award to Carmen Gerlach Assistant Professor Carmen Gerlach, Team Leader at CMM, will receive funding during six years from the Swedish Cancer Society (Cancerfonden) for...

Proteins that protect against joint inflammation identified

Proteins that protect against joint inflammation identified " Endogenous proteins that play a vital part in allergies and parasitic infection can prevent the immune system from wrongly...

New study shows that Proprotein Convertase 6 plays a key role in vascular disease

New study shows that Proprotein Convertase 6 plays a key role in vascular disease In a new study published in Circulation Research, researchers at CMM show that the enzyme PCSK6, the...

Unexpected effect of MS drug

Unexpected effect of MS drug Karl Carlström and Fredrik Piehl Photo: Stefan Zimmerman   Researchers at CMM have studied the mechanism of action of a drug used to treat...

New findings about how Parkinson's disease develops

New findings about how Parkinson's disease develops A new study by researchers at CMM shows that the protein alpha-synuclein, which accumulates in patients with Parkinson’s disease, occurs...

New method divides patients with ulcerative colitis in groups

New method divides patients with ulcerative colitis in groups Researchers at CMM have found a way of using gene expression conserved across species to divide patients with the inflammatory...

Rheumatoid arthritic pain could be caused by antibodies

Rheumatoid arthritic pain could be caused by antibodies In a recently published study, researchers at CMM has shown that antibodies that exist in the joints before the onset of rheumatoid...

Financial support from The Swedish Childhood Cancer Fund to Ann Nordgren for her research position

Financial support from The Swedish Childhood Cancer Fund to Ann Nordgren for her research position Research positions are awarded once a year by the Swedish Childhood Cancer Fund. In 2019,...

Rare disease gives new insight into regulatory T-cell function

Rare disease gives new insight into regulatory T-cell function An international study led by researchers at CMM provides new insights into the regulatory T cells’ role in protecting against...